If the device is used during intraoperative radiation therapy for breast cancer, these particles can be mistaken for suspicious calcifications during follow-up X-rays or scans. ... Abiraterone acetate (Zytiga) to treat metastatic, castration-resistant
He offered a long list of medical problems that can be possibly prevented by vitamin D supplementation: schizophrenia; diabetes; multiple sclerosis; colorectal, breast and prostate cancer; heart attack; stroke; even respiratory ... Sun exposure causes
that uterine bleeding due to endometrial cancer is not dismissed as a diagnosis. ... Brand name: Aleve PM). Abiraterone acetate tablets (250 mg) to treat patients with metastatic castration-resistant prostate cancer.
As the evidence on the utility of prostate-specific antigen screening for prostate cancer continues to be questioned, internists may wonder what to tell their patients about when, how and whether ... Screening can help detect prostate cancer early, but
A second safety net aims to prevent lung cancer by focusing on incidental lung nodules. ... New safety nets that the team is working on include medication safety, prostate cancer, cervical cancer, breast cancer, and diagnostic errors, said Dr.
There's a whole list of options for low-grade prostate cancer, including prostatectomy, hormonal treatments, radiation and watchful waiting.
In 1990, Dr. Gottesman was sued forlate diagnosis of a patient’s prostate cancer.He won the case, and one of the jurors toldhim that the deciding factor had beeninformed consent ... documentation showingthat the patient had been warned that abiopsy
Decisions about prostate cancer treatment can be notoriously complex, with patients and physicians choosing among such options as hormones, radiation, surgery, or watchful waiting. ... Our story in this issue looks at why some experts consider prostate
We have evidence, and practitioners should use that to improve cancer screening rates. ... When Dr. Mulhausen told an 86-year-old man he didn't need to screen for prostate cancer, for example, the patient responded, “So you're just going to give up
In trials of patients with breast and prostate cancer, denosumab increased the length of time to SRE compared to zoledronic acid (Zometa). ... The breast cancer indication for bevacizumab was approved in February 2008 under the FDA's accelerated approval